Milestone

Timeline

2020.01

2020

2020
  • Company name “Tesslift Co., LTD” has changed to “Zishel Medical Co., LTD” to extend the manufacturing portfolio.
  • Showcasing at the 18th Aesthetic & Anti-Aging Medicine World Congress as a Gold Sponsor.
  • CE approved – Tesslift Soft (All of the Tesslift products)
2019.01

2019

  • Showcased at the Dubai World Dermatology & Laser Conference & Exhibition, Dubai Derma 2019.
  • Invited to speak at the 43rd Japan Society of Aesthetic Plastic Surgery.
  • CE registration for Tesslift-160 & Tesslift-020 by UDEM
  • Showcased at the 2019 International Congress of Aesthetic Dermatology.
2018.01

2018

2018
  • Business Agreement for the Exclusivity of Tesslift Products with Zishel Group for the globalization of Tesslift products.
  • Clinical Trial for Tesslift Soft.
  • invited to speak at the 106th Japan Society of Aesthetic Surgery in Tokyo.
  • Showcased at the 2018 International Congress of Aesthetic Dermatology.
2017.01

2017

2017
  • Entitled to ISO 13485 certification (TUV SUD, Germany) for Wonju plant (KFDA).
  • Initial Partner Agreement with Samsung Seoul Hospital for Government R&D project.
  • Registered absorbable TESSLIFT SOFT products by Ministry of Food and Drug Safety.
  • Patent registration for”Device for Tissue Suspension and Fixation”
  • Appointed Hee Jang, BL as the CEO of TESSLIFT Co., Ltd. for his expertise in trading and laws.
  • Showcased at the 15th Aesthetic & Anti-aging Medicine, AMWC.
2015.01

2015-2016

2015-2016
  • Registered 2-dimensional non-absorbable TESSLIFT-020 and TL-010 delivery devices products by Ministry of Food and Drug Safety (KFDA).
  • Registered 3-dimensional non-absorbable TESSLIFT-160 and U Lift-060 products by Ministry Food and Drug Safety (KFDA).
  • Invited to speak at EAM, Indonesia Aesthetic Medicine.
  • Registered absorbable V Lift products by Ministry of Food and Drug Safety (KFDA).
  • Business Agreement for U Lift-060 and V lift products with DN Company, subsidiary of Daewoong Pharm.
  • Showcased at the 2016 International Congress of Korea-Japan-China Aesthetic Surgery & Medicine.
  • Showcased at the 33rd The Congress of Korean Society of Aesthetic Surgery.
  • Established the Corporate R&D Center for implant for tissue suspension.
  • Corporate R&D Center Accreditation by Korea Industrial Technology Association (KOITA).
2014.01

2014

  • Showcased at the 2nd Congress of Asia Anti-Aging & Regenerative Medicine.
  • Showcased at the Asia Forum for Aestheic Surgery & Medicine.
  • Showcased at the 11th Congress of Eastern Cosmetic Surgery.
  • Entitled to KGMP certification on Wonju plant.
  • Registered 2-dimensional non-absorbable TESSLIFT-010 product by Ministry of Food and Drug Safety (KFDA).
2013.01

2013

2013
  • International trademarks registrations for Madrid (Associated countries: Australia, China, EU, Japen, Russia, USA)
  • Live demonstration lecure for TESSLIFT’s products at the 26th Congress of Korean Society of Aestheic Surgery.
  • Established the first plant and head office at Wonju Medical Industry Techno Valley.
  • Registered for manufacturing business for medical devices.
2012.01

2012

2012
  • Patent PCT International Application for “Graft for Tissue Lifting” 9PCT/KR2012/004421
  • Established the OEM Agreement for registered TESSLIFT products.
  • Appointed Dr. Min Kim, MD, as the CEO and Medical Advisory Board Chair of TESSLIFT Co., Ltd. to foster the R&D for TESSLIFT’s products portfolio.
  • Showcased at the 4th International Congress of Minimally Invasive Plastic Surgery.
  • Live demonstration lecture for TESSLIFT products at the 25th Congress of Korean Society of Aesthetic Sugery.
2008.01

2007-2008

2007-2008
  • Collaborations among biomedical engineers and surgeons have established R&D of an implant for tissue suspention.
  • Company name “Jimmy Kim Corp.” has changed to “TESSLIFT Co., Ltd.” (former CEO. Jimmy Kim, the bio-medical engineer).
위로이동